These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 12683470

  • 21. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
    Rush AJ, Trivedi MH, Carmody TJ, Ibrahim HM, Markowitz JC, Keitner GI, Kornstein SG, Arnow B, Klein DN, Manber R, Dunner DL, Gelenberg AJ, Kocsis JH, Nemeroff CB, Fawcett J, Thase ME, Russell JM, Jody DN, Borian FE, Keller MB.
    Neuropsychopharmacology; 2005 Feb; 30(2):405-16. PubMed ID: 15578008
    [Abstract] [Full Text] [Related]

  • 22. Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression.
    Blom MB, Spinhoven P, Hoffman T, Jonker K, Hoencamp E, Haffmans PM, van Dyck R.
    J Affect Disord; 2007 Dec; 104(1-3):119-26. PubMed ID: 17467059
    [Abstract] [Full Text] [Related]

  • 23. Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial.
    Schramm E, Kriston L, Zobel I, Bailer J, Wambach K, Backenstrass M, Klein JP, Schoepf D, Schnell K, Gumz A, Bausch P, Fangmeier T, Meister R, Berger M, Hautzinger M, Härter M.
    JAMA Psychiatry; 2017 Mar 01; 74(3):233-242. PubMed ID: 28146251
    [Abstract] [Full Text] [Related]

  • 24. Therapeutic reactance as a predictor of outcome in the treatment of chronic depression.
    Arnow BA, Manber R, Blasey C, Klein DN, Blalock JA, Markowitz JC, Rothbaum BO, Rush AJ, Thase ME, Riso LP, Vivian D, McCullough JP, Keller MB.
    J Consult Clin Psychol; 2003 Dec 01; 71(6):1025-35. PubMed ID: 14622078
    [Abstract] [Full Text] [Related]

  • 25. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
    Saiz-Ruiz J, Ibañez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F.
    CNS Drugs; 2002 Dec 01; 16(9):635-43. PubMed ID: 12153334
    [Abstract] [Full Text] [Related]

  • 26. Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
    Maddux RE, Riso LP, Klein DN, Markowitz JC, Rothbaum BO, Arnow BA, Manber R, Blalock JA, Keitner GI, Thase ME.
    J Affect Disord; 2009 Oct 01; 117(3):174-9. PubMed ID: 19217168
    [Abstract] [Full Text] [Related]

  • 27. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
    Lespérance F, Frasure-Smith N, Laliberté MA, White M, Lafontaine S, Calderone A, Talajic M, Rouleau JL.
    Can J Psychiatry; 2003 Nov 01; 48(10):695-701. PubMed ID: 14674053
    [Abstract] [Full Text] [Related]

  • 28. Nefazodone for chronic daily headache prophylaxis: an open-label study.
    Saper JR, Lake AE, Tepper SJ.
    Headache; 2001 May 01; 41(5):465-74. PubMed ID: 11380644
    [Abstract] [Full Text] [Related]

  • 29. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder.
    Gillin JC, Smith-Vaniz A, Schnierow B, Rapaport MH, Kelsoe J, Raimo E, Marler MR, Goyette LM, Stein MB, Zisook S.
    J Clin Psychiatry; 2001 Oct 01; 62(10):789-96. PubMed ID: 11816868
    [Abstract] [Full Text] [Related]

  • 30. The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder.
    Neylan TC, Lenoci M, Maglione ML, Rosenlicht NZ, Leykin Y, Metzler TJ, Schoenfeld FB, Marmar CR.
    J Clin Psychiatry; 2003 Apr 01; 64(4):445-50. PubMed ID: 12716248
    [Abstract] [Full Text] [Related]

  • 31. Childhood Trauma Questionnaire-based child maltreatment profiles to predict efficacy of the Cognitive Behavioral Analysis System of Psychotherapy versus non-specific psychotherapy in adults with early-onset chronic depression: cluster analysis of data from a randomised controlled trial.
    Goerigk S, Elsaesser M, Reinhard MA, Kriston L, Härter M, Hautzinger M, Klein JP, McCullough JP, Schramm E, Padberg F.
    Lancet Psychiatry; 2024 Sep 01; 11(9):709-719. PubMed ID: 39147459
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
    Manber R, Kraemer HC, Arnow BA, Trivedi MH, Rush AJ, Thase ME, Rothbaum BO, Klein DN, Kocsis JH, Gelenberg AJ, Keller ME.
    J Consult Clin Psychol; 2008 Jun 01; 76(3):459-67. PubMed ID: 18540739
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS.
    J Clin Psychiatry; 1996 Jun 01; 57 Suppl 2():53-62. PubMed ID: 8626364
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Correlation of subjective and objective sleep measurements at different stages of the treatment of depression.
    Argyropoulos SV, Hicks JA, Nash JR, Bell CJ, Rich AS, Nutt DJ, Wilson SJ.
    Psychiatry Res; 2003 Sep 30; 120(2):179-90. PubMed ID: 14527649
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
    Armitage R, Yonkers K, Cole D, Rush AJ.
    J Clin Psychopharmacol; 1997 Jun 30; 17(3):161-8. PubMed ID: 9169959
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.